Azapropazone

Azapropazone
Azapropazone molecule
Systematic (IUPAC) name
(RS)-5-dimethylamino-9-methyl-2-prop-2-enylpyrazolo[1,2-a][1,2,4]benzotriazine-1,3-dione
Clinical data
Trade names Rheumox
AHFS/Drugs.com International Drug Names
Pharmacokinetic data
Half-life 20 hours
Identifiers
13539-59-8 
M01AX04
PubChem CID 26098
ChemSpider 24310 Yes
UNII K2VOT966ZI Yes
KEGG D02966 Yes
ChEBI CHEBI:38010 Yes
ChEMBL CHEMBL1231131 
Chemical data
Formula C16H20N4O2
300.36 g/mol
  (what is this?)  (verify)

Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.[1]

It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.

Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]

References

  1. http://home.intekom.com/pharm/cont_eth/rheumox.html
  2. http://www.patient.co.uk/showdoc/30002267/
  3. Jones CJ (1976). "The pharmacology and pharmacokinetics of azapropazone - a review". Curr Med Res Opin 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.